288 results about "Glycation" patented technology

The invention discloses an abdominal aortic aneurysm progress prediction method and system based on cross-modal knowledge distillation. The method comprises the following steps: collecting blood of a target object; the method comprises the following steps: detecting the concentration of blood protein fingerprint markers of blood of a target object, wherein the blood protein fingerprint markers comprise matrix metalloproteinase-12, calcitonin-related polypeptide-alpha, uromodulin, nerve injury induction protein-1, glycosylated hemoglobin A1c and fibroblast growth factor-9; carrying out abdominal aortic aneurysm risk calculation by calling Student-net of cross-modal knowledge distillation based on the blood protein fingerprint marker concentration; wherein the input of the Teaser-net of the cross-modal knowledge distillation comprises a CTA image feature and a pathological section feature, and a category probability vector output by the Student-net is aligned with a category probability vector output by the Teaser-net; and outputting the risk level of the abdominal aortic aneurysm and the probability of occurrence / progress / rupture of the abdominal aortic aneurysm in the preset year. And the development of the aortic aneurysm disease is accurately predicted.

The invention discloses a diabetic complication monitoring auxiliary system and method in the technical field of complication monitoring, and the system comprises a data collection module which is used for obtaining local multi-modal data of a user in real time; the federal learning module is used for integrating the local multi-modal data of the user with other anonymous medical databases through a distributed architecture and constructing a multi-family cross-institution complication prediction model; the causal reasoning module is used for analyzing the causal relationship among the blood glucose fluctuation, the glycosylated hemoglobin and the target complication based on an anti-factual causal reasoning algorithm, and outputting a causal effect value to correct the prediction deviation; the prediction module is used for generating occurrence probabilities of future specific complications based on the causal effect values and risk scores output by the complication prediction model, and classifying the occurrence probabilities according to risk levels; and the early warning module is used for generating personalized intervention suggestions according to the risk levels. According to the scheme, the data leakage risk in the data acquisition process is reduced through the federal learning distributed architecture, and the prediction reliability is improved.

The invention discloses a multi-effect repair type collagen and application thereof, and belongs to the technical field of synthetic biology. Transdermal peptide TD-1, a transmembrane region of human XVII type collagen, an extracellular sixteenth non-collagen region, an extracellular fifteenth collagen region and a coding gene of a His tag are selected to be connected in series, and a gene sequence is optimized through pichia pastoris codon selection preference; and then the T-COL17R3 is constructed and expressed to obtain the T-COL17R3. Efficacy experiments prove that compared with similar products sold in the market, T-COL17R3 not only has excellent transdermal performance, but also has better cell proliferation and migration promoting capability, better capability of resisting early saccharification product ketoamine and later saccharification product dicarbonyl compounds, better capability of scavenging free radicals and resisting elastase, and can be used for preparing the anti-epidermal drug. In addition, synthesis of melanin in B16-F10 cells can be reduced, so that T-COL17R3 has excellent application potential in development of pharmaceutical compositions or skin care products with repairing, anti-wrinkle and firming or whitening and brightening effects.

The invention discloses a high-transdermal recombinant humanized XVII type collagen as well as a preparation method and application thereof, and belongs to the technical field of synthetic biology. According to the preparation method, transdermal peptide TD-1, different functional fragments of human XVII type collagen and coding genes of His tags are selected to be connected in series, gene sequences are optimized through pichia pastoris codon selection preference firstly, and then the high-transdermal recombinant humanized XVII type collagen is obtained; and then the recombinant humanized XVII type collagen T-COL17-NC16 and the recombinant humanized XVII type collagen T-COL17 are constructed by expression of the recombinant humanized XVII type collagen T-COL17. Effect experiments prove that compared with similar products sold in the market, the skin-care product has more excellent transdermal performance, can improve cell proliferation and migration ability, also has obvious ability of resisting early saccharification product ketoamine and late saccharification product dicarbonyl compounds, better ability of scavenging free radicals and resisting elastase, and can be used for preparing the skin-care product. Moreover, synthesis of melanin in B16-F10 cells can be reduced, and the compound is expected to become a novel functional biological raw material to be applied to the fields of pharmaceutical compositions or skin care products and the like.

The invention provides a fructus cannabis protein peptide capable of reducing blood sugar and regulating glycometabolism and a preparation method and application thereof, and belongs to the technical field of functional active peptides, and the preparation method comprises the following steps: performing low-temperature supersonic fluid crushing on fructus cannabis, performing enzymolysis pretreatment on the crushed fructus cannabis, adding compound protease for enzymolysis, adding PNGaseF enzyme for further enzymolysis, and performing freeze drying to obtain the fructus cannabis protein peptide capable of reducing blood sugar and regulating glycometabolism. And carrying out membrane ultrafiltration interception and enrichment on the enzymolysis supernatant, carrying out tangential flow filtration, concentrating, drying and sterilizing to obtain the fructus cannabis protein peptide. Tests prove that the novel fructus cannabis protein peptide has the following remarkable effects that the fasting blood glucose level can be remarkably reduced, and uncomfortable symptoms such as thirst, polydipsia, diuresis and weakness caused by hyperglycemia are relieved; the symptoms of glucose intolerance and insulin resistance caused by hyperglycemia can be obviously relieved, and the onset risk of type 2 diabetes mellitus is reduced; the level of fasting serum insulin and glycosylated hemoglobin can be obviously reduced, and the level of serum GLP-1 can be improved.

The invention relates to a composition with antioxidant and brightening effects and capable of delaying skin saccharification as well as a preparation method and application of the composition, and belongs to the field of cosmetics. The composition comprises an ormosia henryi bark extract, tetrahydrocurcumin, a mirabilis jalapa extracting solution, a surfactant, polyol, phospholipid and a solvent. The composition provided by the invention has good illumination stability and high-temperature stability, and the composition provided by the invention is high in bioavailability, and has good antioxidant and brightening effects and lipofuscin and RAGE level inhibition effects.

The invention belongs to the technical field of bioengineering, and particularly relates to a preparation process of nanoscale water-soluble squalene. Comprising the following steps: S1, treating corn flour, adding pure water, and performing enzymolysis by adopting compound enzyme to obtain corn saccharified liquid for later use; s2, inoculating saccharomyces cerevisiae GS-A3 into a culture medium containing the corn saccharification liquid, and fermenting; s3, centrifuging the fermentation liquor, and extracting by adopting supercritical CO2 to obtain a squalene crude product; and S4, carrying out nanocrystallization treatment after molecular distillation treatment. According to the method, corn is taken as a raw material, rich starch resources are utilized, the corn is converted into glucose through enzymolysis, squalene is generated in saccharomyces cerevisiae through an MVA way, high-yield and high-purity squalene is prepared, the stability of squalene is improved through a special nanocrystallization treatment mode, the storage life of squalene in the application process is prolonged, and the method is suitable for industrial production. And the bioavailability can be obviously improved. In addition, the technology used in the invention meets the requirements of green and environmental protection.

The invention relates to a beauty and skin care enzyme and a preparation method thereof. According to the invention, fruits and traditional Chinese medicines are used as main fermentation raw materials, the fruits and the traditional Chinese medicines are crushed and mixed with fermentation strains, and active substances in each raw material are effectively retained through two-stage fermentation, filtration separation and freeze-drying treatment, SOD and sea buckthorn flavone contained in sea buckthorn fruits have the skin care effects of resisting oxidation and promoting collagen synthesis, and the sea buckthorn fruits have the skin care effects of resisting oxidation and promoting collagen synthesis. Salidroside contained in the rhodiola rosea has the skin care effects of resisting light aging and fatigue, astragalus polysaccharide and astragaloside contained in the astragalus membranaceus can repair a barrier and enhance immunity, ophiopogonin and polysaccharide contained in the radix ophiopogonis have the effects of preserving moisture and resisting saccharification, and hesperidin and nobiletin contained in the pericarpium citri reticulatae have the effects of resisting oxidation and adjusting grease secretion. The obtained compound enzyme has the effects of resisting oxidation, resisting inflammation and preserving moisture, has activity, stability and transdermal efficiency, and can be used in skin care products such as anti-oxidation essence, repair masks, late-up cream and the like.

The invention relates to a probiotic preparation containing a BL11 strain and capable of improving obesity-related metabolism and senescence indexes of middle-aged and elderly people and application of the probiotic preparation. The strain in the probiotic preparation is composed of a bifidobacterium longum subsp. Longum BL11 strain and a pediococcus acidilactici PA53 strain. The two strains can cooperate with each other and promote each other, and have a synergistic effect in the aspect of improving obesity-related metabolic indexes, which is specifically embodied in that: the weight increase and body fat rate of mice fed with high fat diet can be reduced; the low-density lipoprotein level, the total cholesterol level and the triglyceride level are reduced, and the high-density lipoprotein level is improved; fasting blood-glucose, glycosylated hemoglobin level and insulin resistance index are reduced; chronic inflammation is relieved; meanwhile, the composition also has excellent performance in the aspect of improving senescence-related indexes, the content of malondialdehyde in serum can be reduced, the activity of superoxide dismutase and glutathione peroxidase can be improved, and the activity of telomerase can be improved.

The invention relates to the technical field of spectral component measurement, in particular to a high performance liquid chromatography detection method of glycosylated hemoglobin for a diabetic pregnant woman. According to the method, high performance liquid chromatograms at different temperatures are obtained, the chromatograms are processed through EMD mode decomposition, screening is carried out according to peak value characteristics, and the IMF component of the hemoglobin component is determined. Matching the IMF components of the hemoglobin components at different temperatures, and obtaining the hemoglobin type of each IMF component of the hemoglobin components according to the obtained temperature matching components and the retention time of the middle components. And counting the content of each hemoglobin type at all temperatures to obtain the content of each hemoglobin type in the blood sample. According to the method, errors in detection are eliminated through chromatographic detection and data statistics, and a more accurate detection result of glycosylated hemoglobin of a diabetic pregnant woman is obtained.

The invention provides an anti-sugar and anti-aging cod collagen peptide as well as a preparation method and application thereof, according to the method, the yield and functional characteristics of active peptide are remarkably improved by combining ultrasonic wave with nanometer grinding pretreatment and combining step-by-step directional enzymolysis and a three-stage ultrafiltration membrane precise separation technology. The method specifically comprises the following steps: carrying out ultrasonic pretreatment on dry cod skin, and then soaking and activating in warm water containing natural anti-sugar components; grinding and dissociating collagenous fibers by adopting high-pressure homogenization and nanoscale zirconium oxide beads; the high-purity peptide fragment with the molecular weight of 500-3000Da is obtained through step-by-step enzymolysis of a compound enzyme I and an enzyme II in combination with gradient interception of a three-stage polyethersulfone ultrafiltration membrane. The total nitrogen content of the obtained product is larger than or equal to 14.5%, the proportion of the target peptide fragment is larger than or equal to 96.7%, the yield is larger than or equal to 18.1%, and the product has remarkable anti-saccharification and anti-aging activity and can be applied to skin care products such as essence and masks to achieve collagen repair and skin barrier function improvement.

The invention relates to the technical field of medical informatics, in particular to an AI-based intelligent early warning system for hyperuricemia male reproductive metabolism abnormality. The system comprises a memory and a processor, and the processor executes a computer program stored in the memory to realize the following steps: acquiring uric acid data, waistline data, glycosylated hemoglobin data and reproductive index data of a target male; combining the uric acid fluctuation abnormality degree, the multi-dimensional blood glucose abnormality expression degree and the movement rule expression degree of each stage to obtain the reproduction metabolism abnormality degree; according to the relative relationship between the reproductive index data and the corresponding standard range, obtaining the abnormal performance degree of the reproductive index; integrating the reproductive metabolism abnormality degree and the reproductive index abnormality expression degree to obtain a multi-dimensional feature linkage reproductive metabolism expression comprehensive evaluation degree of the target male; and according to the comprehensive evaluation degree of the multi-dimensional feature linkage reproductive metabolism performance, whether early warning is carried out is judged. According to the invention, the accuracy and credibility of intelligent early warning of the risk of abnormal male reproductive metabolism of hyperuricemia are improved.

The utility model discloses a multifunctional blood glucose detector for detecting glycosylated hemoglobin, which comprises a shell, a control panel, a screen, a battery pack and a multifunctional detection mechanism, the multifunctional detection mechanism is provided with an electrochemical detection assembly and a photochemical detection assembly which can be used for performing electrochemical detection and photochemical detection on the test strip respectively, and the screen, the battery pack and the multifunctional detection mechanism are electrically connected with the control panel respectively; a user can directly complete electrochemical detection and photochemical detection on one machine in sequence, the operation is convenient, the efficiency is high, and the detection accuracy of glycosylated hemoglobin can be improved by utilizing dual detection.

The invention provides a recognition and early warning method and device for irritable hyperglycemia, electronic equipment and a storage medium, and is applied to the technical field of medical data processing. According to the method, data type information (including FreeStyle LibreH dynamic blood glucose and glycosylated hemoglobin data), influence factor data (improved and preset irritable hyperglycemia index and the like) and abnormal state information (fasting interference and detection difference) are taken; acute-stage and chronic-stage average blood glucose basic data are generated through preprocessing. The index weight is enhanced and improved by means of a dynamic fusion engine, the probability is predicted by combining space-time correlation analysis and binary logistic regression, and the abnormal characteristics are obtained by comparing the difference of the AUC by adopting Delog test. The multi-modal features are processed to obtain an identification result, clinical indexes screened by LASSO are fused, index differences are compared to generate risk influence factors, finally, a dynamic early warning result is generated based on a space-time correlation early warning engine and a multi-target strategy, and accurate identification and early warning are achieved.

The present disclosure relates to systems and methods for measuring glycated A1c hemoglobin. A glycated hemoglobin level measuring system includes a sample testing apparatus having a microchannel that compresses a blood sample traveling through, a first pair of electrodes coupled to the microchannel, and a second pair of electrodes coupled to the microchannel. The glycated hemoglobin level measuring system further includes an analysis apparatus having sensors coupled to the first and second pairs of electrodes and configured to calculate a travel time taken by a red blood cell to pass through the first and second pairs of electrodes. The glycated hemoglobin level measuring system can use the travel time to measure a rigidity of the red blood cells and the corresponding glycated hemoglobin level.

Certain one or more embodiments of the present disclosure are directed, inter alia, to recombinant (genetically modified) filamentous fungal cells (strains) that produce proteins of interest, methods and compositions for designing and constructing modified filamentous fungal cells that produce proteins of interest, for endogenous and / or heterologous proteins of interest (in modified filamentous fungal cells). The present invention relates to methods and compositions for expression / production / secretion / recovery and the like of recombinant filamentous fungi (e.g., phytase, lipase, glucoamylase, phospholipase, esterase, cellulase, hemicellulase, xylanase and the like), methods and compositions for the production of proteins of interest in recombinant filamentous fungi, and methods and compositions for the production of proteins of interest in recombinant filamentous fungi. Wherein the proteins produced and secreted into and / or recovered from the bouillon have a homogeneous and consistent N-linked glycosylation pattern, and / or a (unwanted) reduction in saccharification of one or more proteins of interest, and the like.

Methods of treating, preventing and / or inhibiting one or more of the symptoms of a respiratory viral infection in a subject by administering a therapeutically effective amount of a glycated chitosan (GC) polymer with characteristics as disclosed herein or a vaccine composition comprising such GC polymer in combination with one or more viral antigens are provided. Methods of reducing morbidity and / or mortality of a respiratory viral infection in a subject, methods of inducing an innate immune response in mucosa of a subject, methods of generating mucosal secretory IgA antibodies and / or neutralizing serum IgG antibodies in a subject, and methods of vaccinating a subject against a respiratory viral infection, wherein these methods comprise administering to the subject a therapeutically effective amount of a glycated chitosan (GC) polymer as disclosed herein or a vaccine composition comprising such GC polymer in combination with one or more viral antigens are further provided.

The invention relates to the technical field of Raman scattering, in particular to a high-sensitivity spectrum detection method for glycosylated hemoglobin, which comprises the following steps: acquiring Raman spectrograms corresponding to a preset number of test samples of a patient to be detected, and determining a spectral line increment ascending sequence corresponding to each Raman spectrogram; screening out a smooth change interval, a component peak interval and a trailing possible interval; determining a structure variation index corresponding to each component peak interval; determining a homogeneity index corresponding to each Raman spectrogram; constructing a target matrix, and determining the size of a target window; and replacing the matrix in SERS detection with the target matrix, taking the target window size as the window size in SERS detection, and detecting the glycosylated hemoglobin of the to-be-detected patient through SERS detection. According to the invention, SERS detection of glycosylated hemoglobin is realized, and the rationality of window size setting is improved, so that the accuracy of glycosylated hemoglobin detection is improved.

The invention provides a sugar fat disease death risk prediction method and system based on NHANES data, and the method comprises the steps: obtaining the fasting blood glucose FPG and glycosylated hemoglobin HbA1c clinical detection data of a sugar fat disease patient, and calculating an SHR value through a formula; based on the data of the NHANES database, SHR total cause bilateral critical values of total cause death rate and cardiovascular death rate, SHR cardiovascular bilateral critical values and SHR cancer unilateral critical values of cancer death rate are obtained; and comparing the SHR value with an SHR total cause double-side critical value, an SHR cardiovascular double-side critical value and an SHR cancer single-side critical value of the cancer death rate, and carrying out risk layering and evaluation. The biochemical aging acceleration index has a prediction effect on the diabetes death risk, and KDMAgeAccel significantly intermediates the death risk caused by SHR.

Disclosed are a composition and method for the diagnosis of diseases accompanied by impaired glucose tolerance, comprising a material for ITIH1 detection. The composition and method according to the present application enable a relatively sensitive response even to small changes in blood sugar according to various stimulants in a hyperglycemic situation as compared to glycated hemoglobin (HbA1c) which is an existing diagnostic marker widely used for patients with diabetes, which is a typical disease accompanied by impaired glucose tolerance, and thus can more precisely detect blood sugar changes under various stress situations.

The invention belongs to the technical field of cosmetics, and particularly relates to a cell energy activation composition with an anti-aging effect and a preparation method thereof, the cell energy activation composition with the anti-aging effect and the preparation method thereof are characterized in that the cell energy activation composition with the anti-aging effect comprises the following components: 3-10 parts of thiotaurine and 0.01-0.5 part of a metal ion compound, the composition is prepared from the following raw materials in parts by weight: 0.05-0.5 part of an antioxidant, 0.005-0.05 part of redox regulatory protein, 0.1-6 parts of a raw grass-containing extract, 0.01-1 part of 4-tert-butyl cyclohexanol and 0.05-3 parts of a lipidosome delivery system, according to the invention, multi-channel energy activation is carried out: thiotaurine participates in energy metabolism, metal ions promote enzyme activity, thioredoxin maintains redox balance, and mitochondrial functions are comprehensively improved; liposomal delivery enhances absorption: the transdermal ability of active matters is improved, the stability is enhanced, and the utilization rate is increased; multiple anti-aging mechanisms are as follows: oxidation resistance, saccharification resistance and cell repair.

Described are a recombinant host cell, a composition comprising a glucoamylase and methods of saccharifying the starch substrate using the glucoamylase. Moreover, the disclosure also relates to a process of producing fermentation products and a method for increasing starch digestibility in an animal as well as a method of producing a fermented beverage.

The invention provides a chromatographic detection method capable of accurately detecting the saccharification level of an antibody, the method is used for detecting through a boric acid affinity column, factors influencing the accuracy of a boric acid affinity chromatography (BAC) method of the monoclonal antibody are deeply discussed, reasons for inaccurate saccharification detection of the BAC method of the monoclonal antibody are clarified, an improved BAC method is successfully developed, and the method can be used for detecting the saccharification level of the monoclonal antibody. The saccharification level of infliximab can be measured more accurately, and the accuracy of the method is confirmed through a rapid multi-attribute method based on mass spectrum. In addition, by testing different types of antibody drugs, the wide applicability of the method in conventional antibody drug saccharification detection is proved. The method provides a new rapid and accurate technical scheme for quality control of antibody drugs. The research results are helpful for promoting the improvement of related technical platforms and the updating of concepts, so that the product development and quality control capabilities are enhanced.

The invention relates to a multi-target anti-aging transdermal penetration enhancing composition based on synergistic interaction of PDRN and natural fermentation and application of the multi-target anti-aging transdermal penetration enhancing composition. The composition comprises saccharomycetes / rice fermentation product filtrate, kelp extract and PDRN in a mass ratio of (0.1-20): (0.05-4): (0.01-3), and is prepared according to the following steps: adding a solvent and a humectant into a container, and continuously stirring until the solvent and the humectant are completely dissolved; adding a chelating agent and a skin conditioner, and performing heat-preservation stirring until a system is uniform and transparent; adding the emulsifier, preserving heat and stirring until the emulsifier is completely dissolved; stopping heating, cooling, adding the functional components and the preservative, and stirring until the components are uniformly mixed; and quantitatively filling in a sterile environment. Compared with the prior art, the hydration environment of the yeast / rice fermentation product filtrate improves the transdermal efficiency of the kelp extract and PDRN; the kelp extract eliminates ROS, resists saccharification and reduces oxidative damage; the deep repair function of the PDRN reversely enhances the epidermis repair effect of the PDRN and the PDRN, and a synergistic effect of '1 + 1 + 1gt; 3' is formed.

The application belongs to the technical field of biological medicine, and particularly relates to a preparation method and application of a styrene microsphere for glycosylated hemoglobin detection. The styrene microsphere is prepared through a dispersion polymerization method, a seed polymerization method and a preparation step of organic high molecular particles. The microsphere prepared in the application has moderate particle size and concentrated distribution, good uniformity of the microsphere particle size, a hydroxyl covering on the surface of the microsphere to form a hydrophilic layer, and can effectively reduce the matrix effect, so as to achieve accurate analysis of glycosylated hemoglobin HbA1c. The result is accurate, stable and small in error in the detection, and the application can be applied to quantitative detection of diabetes.

The invention relates to the technical field of gelators and functional cosmetics, in particular to a porphyrin core-based gelator, preparation thereof and application of the porphyrin core-based gelator in preparation of products for removing skin glycated toxins. The gel factor provided by the invention is a C2 symmetric chiral gel factor: L-Por-Phe. A central core (porphyrin ring) of the gelator provides strong hydrophobic acting force and pi-pi stacking driving force, is not only a driving core for supramolecular self-assembly, but also is a key site for adsorbing aromatic AGEs toxins; a natural chiral source and an additional benzene ring side group are introduced into a side chain, the hydrophilic-hydrophobic balance of molecules is adjusted, and a supramolecular assembly is induced to form a single chiral spiral nanofiber; the connecting arms provide intermolecular hydrogen bonds to stabilize the three-dimensional network structure of the hydrogel; the terminal group endows the molecule with pH responsiveness, so that the gel can maintain a stable gel state in a skin physiological pH environment, and has good moisture retention.

The application discloses a kind of multi-effect repair type collagen and its application in the technical field of synthetic biology, the application selects transdermal peptide TD-1, the coding gene of the transmembrane region of human XVII type collagen, extracellular sixteenth non-collagen region and extracellular fifteenth collagen region and His tag is connected in series, and gene sequence is optimized by pichia pastoris codon selection preference, then obtains T-COL17R3 by construction and expression. Through efficacy experiment, it is verified that T-COL17R3 compared with similar products on sale, not only excellent transdermal performance, also has more optimal ability of promoting cell proliferation, migration, anti early glycation product ketone amine and anti late glycation product dicarbonyl compound, better free radical scavenging ability and anti-elastase ability, and can reduce the synthesis of melanin in B16-F10 cell, therefore, T-COL17R3 has excellent application potential in the development of drug composition or skin care product with repair, anti-wrinkle firming or whitening effect.

Embodiments provide for methods of predicting glycation percentage of an amino acid in a therapeutic biomolecule. In one example, a method of predicting a glycation percentage of an amino acid in a biomolecule includes determining a first set of rates for a de-glycation reaction for a first set of temperatures, inferring a second set of one or more rate(s) for the de-glycation reaction for a second set of temperatures, and using the second set of one or more rate(s) to predict the glycation percentage at any temperature corresponding to the second set of temperatures and over any time duration. Also provided are methods for maintaining a glycation percentage of an amino acid within a predetermined glycation percentage range over a shelf-life of a therapeutic biomolecule, and methods for either reducing or increasing a potency of a therapeutic biomolecule in a subject at a time of administration.

Provided is a Bifidobacterium bifidum strain, Bifidobacterium bifidum ibiome001, which can significantly reduce body weight gain and white adipose tissue weight gain of high fat diet-induced obese and diabetic mice, and enhances expression of lipolytic genes ATGL and HSL. Moreover, Bifidobacterium bifidum ibiome001 can significantly lower fasting blood glucose levels, area under curves (AUCs) of the oral glucose tolerance (OGTT) curve, plasma glycated hemoglobin levels and insulin levels of diabetic mice. It is suggested that Bifidobacterium bifidum ibiome001 is a promising potential probiotic strain for the treatment of metabolic syndrome such as obesity, diabetes and the like, which is more effective than other Bifidobacterium strains / compositions.

The invention discloses a method for hydrolyzing and saccharifying wood fiber biomass. The method is characterized by comprising the following steps: (1) washing and drying materials; (2) crushing the materials; (3) preparing a material pretreatment solvent; (4) delignification of the material in a pretreatment solvent; (5) filtering the reaction liquid at normal temperature and normal pressure to separate liquid from solid to obtain cellulose; and (6) adding cellulose and polypeptide into deionized water according to a ratio of 2: 1-1: 2 in a solid-to-liquid ratio of 1: 50-1: 100, adding a NaOH solution to adjust the pH value of the solution to 3-8, and reacting at 40-95 DEG C under the protection of nitrogen for 6-16 hours to obtain the product glucose.